Who
Alan List
Director
Company insider
Files Form 4 as: Director, TuHURA Biosciences; Chief Medical Officer, Precision BioSciences.
In numbers
- Trades disclosed
- 28
- Buys
- 0
- Sells
- 6
- Bought
- $0
- Sold
- $46K
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 7 Jun 2021
- Last trade
- 12 Feb 2026
- Last filed
- 17 Feb 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 12 Feb 2026filed 17 Feb 2026 | HURA TuHURA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —156,240 at $0.00 | filing |
| 12 Feb 2026filed 17 Feb 2026 | HURA TuHURA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —156,240 at $0.00 | filing |
| 2 Jan 2025filed 6 Jan 2025 | HURA TuHURA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —51,275 at $0.00 | filing |
| 18 Oct 2024filed 22 Oct 2024 | HURA TuHURA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —13,553 at $0.00 | filing |
| 18 Oct 2024filed 22 Oct 2024 | HURA TuHURA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —13,553 at $0.00 | filing |
| 2 May 2024filed 3 May 2024 | DTIL Precision BioSciencesBiotechnology | SEC FORM 4 Sold | $2,993290 at $10.32 | filing |
| 1 May 2024filed 3 May 2024 | DTIL Precision BioSciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —982 at $0.00 | filing |
| 1 May 2024filed 3 May 2024 | DTIL Precision BioSciencesBiotechnology | SEC FORM 4 Code M | —982 | filing |
| 30 Apr 2024filed 30 Apr 2024 | DTIL Precision BioSciencesBiotechnology | SEC FORM 4 Sold | $2,387238 at $10.03 | filing |
| 26 Apr 2024filed 30 Apr 2024 | DTIL Precision BioSciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —868 at $0.00 | filing |
| 26 Apr 2024filed 30 Apr 2024 | DTIL Precision BioSciencesBiotechnology | SEC FORM 4 Code M | —868 | filing |
| 22 Jan 2024filed 23 Jan 2024 | DTIL Precision BioSciencesBiotechnology | SEC FORM 4 Sold | $7,74921,526 at $0.36 | filing |
| 20 Jan 2024filed 23 Jan 2024 | DTIL Precision BioSciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —60,012 at $0.00 | filing |
| 20 Jan 2024filed 23 Jan 2024 | DTIL Precision BioSciencesBiotechnology | SEC FORM 4 Code M | —60,012 | filing |
| 27 Apr 2023filed 28 Apr 2023 | DTIL Precision BioSciencesBiotechnology | SEC FORM 4 Sold | $6,1397,771 at $0.79 | filing |
| 26 Apr 2023filed 28 Apr 2023 | DTIL Precision BioSciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —26,027 at $0.00 | filing |
| 26 Apr 2023filed 28 Apr 2023 | DTIL Precision BioSciencesBiotechnology | SEC FORM 4 Code M | —26,027 | filing |
| 6 Mar 2023filed 7 Mar 2023 | DTIL Precision BioSciencesBiotechnology | SEC FORM 4 Sold | $10K9,473 at $1.07 | filing |
| 3 Mar 2023filed 7 Mar 2023 | DTIL Precision BioSciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —29,453 at $0.00 | filing |
| 3 Mar 2023filed 7 Mar 2023 | DTIL Precision BioSciencesBiotechnology | SEC FORM 4 Code M | —29,453 | filing |
News
Precision BioSciences, Inc. (NASDAQ:DTIL) Stock Has Consensus Price Target of $32.25DTIL · themarketsdaily.com · 17 Oct 2026
0 headlines in the last 90 days name Alan List; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.